Henriette Arts

Henriette Arts is a researcher specializing in gynecologic oncology and surgical oncology, focusing on advanced ovarian cancer and hyperthermic intraperitoneal chemotherapy (HIPEC). Her work contributes to UN Sustainable Development Goals related to health and well-being. She is a core member of the OVHIPEC-1 Study Group, leading clinical trials evaluating HIPEC efficacy and patient stratification in ovarian cancer.

Research interests include tumor microenvironment characterization, cytoreductive surgery outcomes, genomic profiling (e.g., HRD/BRCA status), and improving clinical practice adherence in surgical staging. Her studies bridge surgical techniques, molecular biology, and clinical outcomes to optimize cancer care.

Key collaborations involve multidisciplinary teams across institutions, including researchers like Aronson, Sonke, and van Driel. Her work has been highlighted in The Lancet Oncology and referenced in patents and news outlets. She actively contributes to advancing HIPEC protocols and understanding ovarian cancer heterogeneity.